Approaches to virtual library design

Drug Discovery Today

Volumn 3, Issue 6, 1998, Pages 274-283

  Van Drie, John H ^a   Lajiness, Michael S ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER PROGRAM; LIBRARY; MEDICAL INFORMATION; REVIEW; VIRTUAL REALITY;

EID: 0031831627     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(98)01186-6     Document Type: Review

References (45)

1. Ellman J.A. Acc. Chem. Res. 29:1996;132-143.
2. Müller K. J. Mol. Struc. (Theochem). 0:1997;398-399-467-471.
3. Lewis R.A., Mason J.S., McLay I.M. J. Chem. Inf. Comput. Sci. 37:1997;599-614.
4. Willett, P. (1987) Similarity and Clustering in Chemical Information Systems, Wiley.
5. Willett P., Winterman V., Bawden D. J. Chem. Inf. Comput. Sci. 26:1986;109-118.
6. Bawden, D. (1990) in Chemical Structures 2 (Warr, W., ed.) pp. 173-176, Springer.
7. Lajiness, M.S., Johnson, M.A. and Maggiora, G.M., (1989) QSAR: Quantitative Structure-Activity Relationships in Drug Design (Fauchère, J.L., ed.), Alan R. Liss, New York.
8. Lajiness, M.S. (1990) in Computational Chemical Graph Theory (Rouvray, D.H., ed.), Nova Science Publishers, New York.
9. Maggiora G.M.et al. Math. Comput. Modeling. 11:1988;630-634.
10. Geysen H.M., Mason T.J. Bioorg. Med. Chem. Lett. 3:1993;397-404.
11. Pavia M.R., Sawyer T.K., Moos W.H. Bioorg. Med. Chem. Lett. 3:1993;387-396.
12. Bunin B.A., Ellman J.A. J. Am. Chem. Soc. 114:1992;10997-10998.
13. DeWitt S.H.et al. Proc. Natl. Acad. Sci. U. S. A. 90:1993;6909-6913.
14. Ferguson A.M.et al. J. Biomol Screening. 1:1996;65-73.
15. Garr C.D.et al. J. Biomol. Screening. 3:1996;179-186.
16. Kick E.K.et al. Chem. Biol. 4:1997;297-307.
17. Adamson G.W.et al. J. Chem. Doc. 13:1973;153-157.
18. Adamson G.W.et al. J. Chem. Doc. 14:1974;44-48.
19. Hodes L.J. J. Chem. Inf. Comput. Sci. 16:1976;88-93.
20. Hodes L.J., Feldman A. J. Chem. Inf. Comput. Sci. 18:1978;96-100.
21. Graf W.et al. J. Chem. Inf. Comput. Sci. 19:1979;51-55.
22. Howe W.J., Hagadone T.R. J. Chem. Inf. Comput. Sci. 22:1982;8-15.
23. Cramer R.D.et al. J. Med. Chem. 39:1996;3060-3069.
24. Patterson D.E.et al. J. Med. Chem. 39:1996;3049-3059.
25. Brown R.D., Martin Y.C. J. Med. Chem. 40:1997;2304-2313.
26. Hassan M.et al. Mol. Diversity. 2:1996;64-74.
27. Sadowski J., Wagener M., Gasteiger J. Angew. Chem., Int. Ed. Engl. 34:1995;2674-2677.
28. Mason J.S., Pickett S.D. Perspect. Drug Des. Discovery. 7:1997;1-29.
29. Good A.C., Lewis R.A. J. Med. Chem. 40:1997;3926-3936.
30. Wipf P.et al. Bioorg. Med. Chem. 5:1997;165-177.
31. Van Drie J.H., Nugent R.A. SAR and QSAR Environ. Res. 9:1998;1-21.
32. Van Drie J.H. J. Comput.-Aided Mol. Design. 10:1996;623-630.
33. Van Drie J.H. J. Comput.-Aided Mol. Design. 11:1997;39-52.
34. Van Drie J.H. J. Chem. Inf. Comput. Sci. 37:1997;38-42.
35. Baldwin E.T.et al. Proc. Natl. Acad. Sci. U. S. A. 90:1993;6796-6800.
36. Lewis R.A.et al. J. Mol. Graph. 10:1992;66-78.
37. Roe D.C., Kuntz I.D. J. Comput.-Aided Mol. Design. 9:1995;269-282.
38. Rockwell A.et al. J. Am. Chem. Soc. 118:1996;10337-10338.
39. Hilpert K.et al. J. Med. Chem. 37:1994;3889-3901.
40. Young S.S., Hawkins D.M. J. Med. Chem. 38:1995;2784-2788.
41. Higgs R.E.et al. J. Chem. Inf. Comput. Sci. 37:1997;861-870.
42. Lipinski C.A.et al. Adv. Drug Deliv. Rev. 23:1997;3-25.
43. Martin, E.J. and Critchlow, R.E. (1997) 213th ACS National Meeting, 13-17 April, San Francisco, CA, USA (CINF 0003).
44. Gillet V.J., Willett P., Bradshaw J. J. Chem. Inf. Comput. Sci. 37:1997;731-740.
45. Brown R.D., Martin Y.C. J. Chem. Inf. Comput. Sci. 36:1996;572-584.